Novocure End Period Cash Flow from 2010 to 2025

NVCR Stock  USD 18.44  0.33  1.76%   
Novocure End Period Cash Flow yearly trend continues to be relatively stable with very little volatility. End Period Cash Flow is likely to grow to about 168.1 M this year. During the period from 2010 to 2025, Novocure End Period Cash Flow destribution of quarterly values had range of 188.6 M from its regression line and mean deviation of  41,821,667. View All Fundamentals
 
End Period Cash Flow  
First Reported
2013-12-31
Previous Quarter
189.2 M
Current Value
166.1 M
Quarterly Volatility
118.5 M
 
Yuan Drop
 
Covid
Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.2 M, Selling General Administrative of 97.7 M or Selling And Marketing Expenses of 251 M, as well as many indicators such as Price To Sales Ratio of 5.04, Dividend Yield of 0.0 or PTB Ratio of 13.33. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.
  
Check out the analysis of Novocure Correlation against competitors.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Latest Novocure's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Novocure over the last few years. It is Novocure's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Pretty Stable
   End Period Cash Flow   
       Timeline  

Novocure End Period Cash Flow Regression Statistics

Arithmetic Mean158,095,223
Geometric Mean148,096,308
Coefficient Of Variation33.77
Mean Deviation41,821,667
Median175,894,000
Standard Deviation53,396,002
Sample Variance2851.1T
Range188.6M
R-Value0.26
Mean Square Error2855.2T
R-Squared0.07
Significance0.34
Slope2,866,496
Total Sum of Squares42767T

Novocure End Period Cash Flow History

2025168.1 M
2024166.1 M
2023242.6 M
2022115.8 M
2021209.6 M
2020246.2 M
2019179.4 M

About Novocure Financial Statements

Novocure shareholders use historical fundamental indicators, such as End Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Novocure investors may analyze each financial statement separately, they are all interrelated. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novocure's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
End Period Cash Flow166.1 M168.1 M

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.